Dissecting Associations Of Estradiol And Testosterone With Cardiovascular Outcomes.
Funder
National Health and Medical Research Council
Funding Amount
$435,082.00
Summary
Controversy persists over whether falling testosterone (T) levels in ageing men increase risk of cardiovascular disease (CVD). T is converted by the enzyme aromatase into estradiol (E2). We will assess whether men with abnormal E2 levels are at risk of CVD, more so than men with low T. We will assess whether differences in the aromatase gene which alter E2 levels also influence the risk of CVD. The results will clarify the importance of hormones to CVD and guide new approaches to its treatment.
Randomised Phase II Trial Of Neoadjuvant Chemotherapy +/- Concurrent Aromatase Inhibitor Endocrine Therapy To Down-stage Large Oestrogen Receptor Positive Breast Cancer
Funder
National Health and Medical Research Council
Funding Amount
$2,302,496.00
Summary
Women diagnosed with large oestrogen receptor positive breast cancer are often treated with chemotherapy before surgery to reduce the size of the cancer, while treatment to lower oestrogen levels is given after surgery. This trial is studying if combining chemotherapy with oestrogen lowering treatment before surgery will better shrink the cancer which can improve the surgery options.